Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has demonstrated significant efficacy in metabolic research. It works by mimicking the GLP-1 hormone, which stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner. Our pharmaceutical-grade semaglutide is produced via solid-phase peptide synthesis (SPPS) with rigorous quality control at every stage.